XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Net Unrealized (Losses) Gains on Investments [Member]
Foreign Currency Translation (Losses) Gains [Member]
Nonredeemable Noncontrolling Interests [Member]
Balance at Dec. 31, 2022 $ 81,450 $ 9 $ 0 $ 86,156 $ (2,778) $ (5,615) $ 3,678
Balance (in shares) at Dec. 31, 2022   934          
Net earnings attributable to UnitedHealth Group common shareholders 16,926     16,926      
Net earnings attributable to nonredeemable noncontrolling interest             401
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 17,327            
Other comprehensive income (loss) (295)       (549) 254  
Issuances of common stock, and related tax effects (in shares)   4          
Issuances of common stock, and related tax effects 963 $ 0 963        
Share-based compensation 833   833        
Common share repurchases (in shares)   (13)          
Common share repurchases (6,549) $ 0 (1,663) (4,886)      
Cash dividends paid on common shares (5,023)     (5,023)      
Redeemable noncontrolling interests fair value and other adjustments (133)   (133)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 1,339           1,339
Distribution to nonredeemable noncontrolling interests (348)           (348)
Balance at Sep. 30, 2023 $ 89,564 $ 9 0 93,173 (3,327) (5,361) 5,070
Balance (in shares) at Sep. 30, 2023   925          
Common Stock, Dividends, Per Share, Cash Paid $ 5.41            
Balance at Jun. 30, 2023 $ 87,368 $ 9 0 89,994 (2,643) (5,007) 5,015
Balance (in shares) at Jun. 30, 2023   927          
Net earnings attributable to UnitedHealth Group common shareholders 5,841     5,841      
Net earnings attributable to nonredeemable noncontrolling interest             149
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 5,990            
Other comprehensive income (loss) (1,038)       (684) (354)  
Issuances of common stock, and related tax effects (in shares)   1          
Issuances of common stock, and related tax effects 395 $ 0 395        
Share-based compensation 235   235        
Common share repurchases (in shares)   (3)          
Common share repurchases (1,511) $ 0 (588) (923)      
Cash dividends paid on common shares (1,739)     (1,739)      
Redeemable noncontrolling interests fair value and other adjustments (42)   (42)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 42           42
Distribution to nonredeemable noncontrolling interests (136)           (136)
Balance at Sep. 30, 2023 $ 89,564 $ 9 0 93,173 (3,327) (5,361) 5,070
Balance (in shares) at Sep. 30, 2023   925          
Common Stock, Dividends, Per Share, Cash Paid $ 1.88            
Balance at Dec. 31, 2023 $ 94,421 $ 9 0 95,774 (1,971) (5,056) 5,665
Balance (in shares) at Dec. 31, 2023 924 924          
Net earnings attributable to UnitedHealth Group common shareholders $ 8,862     8,862      
Net earnings attributable to nonredeemable noncontrolling interest             462
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 9,324            
Other comprehensive income (loss) 4,574       557 4,017  
Issuances of common stock, and related tax effects (in shares)   7          
Issuances of common stock, and related tax effects 1,280 $ 0 1,280        
Share-based compensation 770   770        
Common share repurchases (in shares)   (8)          
Common share repurchases (4,045) $ 0 (1,528) (2,517)      
Cash dividends paid on common shares (5,601)     (5,601)      
Redeemable noncontrolling interests fair value and other adjustments (61)   (61)        
Acquisition and other adjustments of nonredeemable noncontrolling interests (291)           (291)
Distribution to nonredeemable noncontrolling interests (490)           (490)
Balance at Sep. 30, 2024 $ 99,881 $ 9 461 96,518 (1,414) (1,039) 5,346
Balance (in shares) at Sep. 30, 2024 923 923          
Common Stock, Dividends, Per Share, Cash Paid $ 6.08            
Balance at Jun. 30, 2024 $ 94,676 $ 9 373 92,400 (2,296) (1,127) 5,317
Balance (in shares) at Jun. 30, 2024   921          
Net earnings attributable to UnitedHealth Group common shareholders 6,055     6,055      
Net earnings attributable to nonredeemable noncontrolling interest             155
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 6,210            
Other comprehensive income (loss) 970       882 88  
Issuances of common stock, and related tax effects (in shares)   4          
Issuances of common stock, and related tax effects 842 $ 0 842        
Share-based compensation 208   208        
Common share repurchases (in shares)   (2)          
Common share repurchases (957) $ 0 (957) 0      
Cash dividends paid on common shares (1,937)     (1,937)      
Redeemable noncontrolling interests fair value and other adjustments (5)   (5)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 28           28
Distribution to nonredeemable noncontrolling interests (154)           (154)
Balance at Sep. 30, 2024 $ 99,881 $ 9 $ 461 $ 96,518 $ (1,414) $ (1,039) $ 5,346
Balance (in shares) at Sep. 30, 2024 923 923          
Common Stock, Dividends, Per Share, Cash Paid $ 2.10